Files

Download

Download Full Text (1.0 MB)

Keywords

Antibody-Drug Conjugates; Synovial Sarcoma

Abstract

Synovial sarcomas (SS) are rare soft tissue cancers that are found beside bone in children and adolescents. Currently, the prognosis for these diseases are low, as diagnostic and treatment options are limited due to the rarity of the disease. With high rates of metastasis, treatment options for these diseases become further limited to primarily radiation and chemotherapies. These therapies have limited specificity in their mechanisms, causing severe side effects in patients. This work examined alternative options for synovial sarcoma theranostic approaches, specifically using immunoconjugates for Oncostatin M Receptors (OSMR). This receptor was chosen due to the high rate of expression of Oncostatin M in many cancers, including synovial sarcoma. It is involved in cancer proliferation and metastasis, making it a good target for treatment.

Document Type

Poster

Publication Date

2024-03-21

Language

English

College

Life Sciences

Department

Cell Biology and Physiology

University Standing at Time of Publication

Senior

Theranostic Approaches to Treat Synovial Sarcoma

Included in

Biology Commons

Share

COinS